drug
monepantel
Phase 3updated 5mo agoby Neurizon Therapeutics Ltd
Phase 3community read0 votes
indications
indications
ALS
all catalysts(0)
nothing on the calendar yet
Trials studying monepantel
News(1)
- Axoltis misses the mark in phase 2 ALS study, but will persevere with the synthetic peptideAxoltis Pharma's phase 2 trial for amyotrophic lateral sclerosis may have missed its primary endpoint, but the French biotech has pointed to secondary endpoints to justify persevering with the synt…fiercebiotech · 15d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that